- Remington Report - https://remingtonreport.com -

IMPACT Act – Cross-Setting Quality Measure for Medication Reconciliation

CMS has contracted with Abt Associates and RTI International to develop a cross-setting Post-Acute Care measure for the quality measure domain – medication reconciliation.

In this measure, medication reconciliation and drug regimen review are defined as:

Medication Reconciliation – the process of comparing the medications a patient is taking (and should be taking) with newly ordered medications in order to identify and resolve discrepancies. (Reference: The Joint Commission, National Patient Safety Goals).

Drug Regimen Review – a review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. (Reference: Home Health Conditions of Participation §484.55c).

“CMS has contracted with Abt Associates and RTI International to develop a cross-setting Post-Acute Care measure for the quality measure domain – medication reconciliation.”

Project Objectives:

Documents and Measures for Comment:


Print Friendly, PDF & Email